Real-world Use Supports Effectiveness of Advate, Adynovate, and Feiba, Takeda Data Show
News
Takeda presented new real-world data highlighting the underdiagnosis of hemophilia A and B, supporting the effectiveness and safety of its hemophilia therapies — Advate, Adynovate, and Feiba — and discussing potential benefits of ... Read more